Centessa   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: London United Kingdom (2014)

Organization Overview

First Clinical Trial
2019
NCT04073498
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ApcinteX Ltd | Z Factor Limited